FY2027 EPS Estimates for ISRG Reduced by Erste Group Bank

Key Points

• Erste Group Bank cut FY2027 EPS for Intuitive Surgical to $9.52 from $9.54, while the consensus estimate for the company's current full-year earnings sits at $6.43 per share.
• Recent quarterly results beat expectations: Intuitive reported $2.53 EPS versus $2.27 expected and revenue of $2.87 billion (versus $2.72 billion), with revenue up 18.8% year‑over‑year.
• Analyst sentiment remains positive—the consensus rating is "Moderate Buy" with an average target of $611.77; ISRG trades around $452.95 with a market cap of about $160.9 billion and a P/E of 57.41.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) - Erste Group Bank cut their FY2027 earnings per share (EPS) estimates for Intuitive Surgical in a report issued on Thursday, April 2nd. Erste Group Bank analyst H. Engel now expects that the medical equipment provider will post earnings of $9.52 per share for the year, down from their previous estimate of $9.54. The consensus estimate for Intuitive Surgical's current full-year earnings is $6.43 per share.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analysts' expectations of $2.72 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. The company's revenue was up 18.8% compared to the same quarter last year.

A number of other research firms also recently weighed in on ISRG. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an "outperform" rating for the company in a research report on Friday, January 23rd. BTIG Research reissued a "buy" rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. The Goldman Sachs Group reissued a "buy" rating and set a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Piper Sandler reissued an "overweight" rating and set a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Sanford C. Bernstein raised their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an "outperform" rating in a research report on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $611.77.

Intuitive Surgical Trading Up 0.1%

ISRG stock opened at $452.95 on Wednesday. Intuitive Surgical has a twelve month low of $427.84 and a twelve month high of $603.88. The company has a market capitalization of $160.86 billion, a P/E ratio of 57.41, a PEG ratio of 3.49 and a beta of 1.68. The firm has a 50 day simple moving average of $484.46 and a 200-day simple moving average of $514.43.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in ISRG. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $25,000. Newbridge Financial Services Group Inc. boosted its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after buying an additional 33 shares during the period. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $27,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 421 shares of the business's stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 2,362 shares of the business's stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares of the company's stock, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.